Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

Presentation Stanford Coronary Physiology Conference 2016

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

Presenter: William F. Fearon

October 28, 2016

News Daily News

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Michael O'Riordan

July 27, 2016

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

Caitlin E. Cox

May 19, 2016

News Industry News

St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan

February 07, 2016

News Conference News TCT 2015

FFR Guidance Could Reduce Need for Multivessel Primary PCI

October 11, 2015

News Daily News

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

Yael L. Maxwell

October 24, 2014

News Conference News ESC 2014

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

Caitlin E. Cox

September 02, 2014

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

Yael L. Maxwell

November 14, 2013

Presentation TCT 2013

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

Presenter: Hong-Seok Lim

October 29, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Angiography May Overestimate Disease Severity vs. FFR in Women

Caitlin E. Cox

June 20, 2013

News Daily News

Study Suggests FFR Diagnostic ‘Gray Zone’ Complicates Clinical Decision Making

L.A. McKeown

March 25, 2013

News Daily News

FFR Improves Outcomes in Routine Clinical Practice

Jason Kahn

February 04, 2013

Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

October 24, 2012

News Conference News ESC 2012

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

August 28, 2012

News Daily News

Perfusion Imaging Guidance for Revascularization Improves Outcomes

July 11, 2012

News Conference News EuroPCR 2012

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

Caitlin E. Cox

May 15, 2012

News Daily News

FFR Plus Syntax Score Equals Better Risk Stratification in Multivessel Patients

L.A. McKeown

September 12, 2011

Advertisement

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Will FFR-Directed PCI Be Better Than CABG? Update on the FAME 3 trial

PLATFORM: FFRCT-Guided Strategy in Suspected CAD ‘Durable’ Out to 1 Year

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan

FFR Guidance Could Reduce Need for Multivessel Primary PCI

Meta-analysis Confirms Benefits of FFR-Guided Revascularization

FAME 2: FFR-Guided PCI Continues on Same Trajectory from 1 to 2 Years

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

SCAI Paper Outlines ‘Best Practices’ for FFR, IVUS, OCT

TCT-76. Does Age Affect Fractional Flow Reserve-Guided Percutaneous Coronary Intervention? A FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Trial...

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Angiography May Overestimate Disease Severity vs. FFR in Women

Study Suggests FFR Diagnostic ‘Gray Zone’ Complicates Clinical Decision Making

FFR Improves Outcomes in Routine Clinical Practice

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

FAME 2: PCI Bests Medical Therapy in Stable Patients with Proven Ischemia

Perfusion Imaging Guidance for Revascularization Improves Outcomes

FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy

FFR Plus Syntax Score Equals Better Risk Stratification in Multivessel Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content